핵의학 이미징 장비 시장 규모 조사 및 예측 : 모달리티별, 용도별, 최종 용도별, 지역별 분석(2023-2030년)

Global Nuclear Imaging Equipment Market is valued approximately at USD 6.21 billion in 2022 and is anticipated to grow with a growth rate of more than 3.14% over the forecast period 2023-2030. Nuclear imaging equipment refers to advanced medical devices used in diagnostic imaging procedures that involve the use of radioactive substances to create detailed images of organs and tissues within the body. These imaging modalities utilize various techniques such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET) to detect and visualize metabolic and functional changes at the molecular level. The Nuclear Imaging Equipment market is expanding because of factors such as increasing incidence of cancer and cardiovascular diseases, increasing investments in healthcare infrastructure and rising adoption of hybrid imaging systems.

The rising prevalence of cancer and cardiovascular diseases worldwide is driving the demand for advanced diagnostic imaging technologies, including nuclear imaging equipment. These imaging modalities play a crucial role in the early detection, staging, and monitoring of cancer and heart conditions, contributing to better patient outcomes. According to the International Agency for Research on Cancer (IARC), the projected global cancer burden is expected to rise to 27.5 million new cases by 2040, a significant increase from the 1.9 million new cases reported in 2021. Moreover, the Centers for Disease Control and Prevention (CDC) 2022 report states that in 2020, 20.1 million persons aged 20 and older had coronary artery disease. Furthermore, the same report stated that every year about 805,000 Americans have a heart attack. Thus, rising chronic cardiac diseases are driving the market growth. Moreover, the National Library of Medicine announced in September 2022 that more than 200,000 heart valve replacement procedures are carried out annually worldwide, with an increase to 8,50,000 per year expected by 2050. Thus, rising prevalence of cancer and cardiovascular diseases is driving the market growth. In addition, expanding applications in neurology and oncology and favorable reimbursement policies for nuclear imaging procedures are creating new opportunities the market growth. However, the high cost of nuclear imaging equipment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Nuclear Imaging Equipment Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to expanding elderly population and the escalating incidence of chronic ailments spurred by lifestyle shifts, thereby driving up the demand for nuclear medicine imaging procedures. Additionally, the proactive engagement of prominent industry players in the region through diverse initiatives aimed at bolstering their market presence is anticipated to further bolster regional growth. Asia Pacific is expected to grow at a fastest rate during the forecast period, owing to factors such as rising incidence of cancer, alongside the introduction of state-of-the-art nuclear imaging equipment in the region, is poised to propel market expansion.

Major market player included in this report are:

• GE HealthCare
• Siemens Healthineers
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Mediso, Cubresa Inc.
• Shimadzu Corporation
• United Imaging Healthcare Co
• BCL X-Ray Canada Inc.
• TTG Imaging Solutions, LLC.
• Lucerno Dynamics LLC.

Recent Developments in the Market:

• In May 2023, Koninklijke Philips N.V., Elekta, and Mercurius Health revealed a collaborative 3-year agreement. Within this alliance, Philips and Elekta joined forces to install cutting-edge diagnostic and therapeutic oncology equipment, alongside aligned informatics solutions, at Mercurius Health's recently acquired Robert Janker Klinik cancer center in Bonn, Germany.
• In April 2022, Mediso Ltd disclosed its acquisition of Bartec Technologies Ltd, a UK-based company specializing in the supply, installation, and support of Nuclear Medicine and Molecular Imaging equipment and accessories. This strategic move is anticipated to fortify Mediso's foothold in the UK and Ireland markets.

Global Nuclear Imaging Equipment Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Modality, application, End-use, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Modality:

• SPECT
• PET

By Application:

• Cardiology
• Oncology
• Neurology
• Others

By End-use:

• Hospitals
• Imaging Centers
• R&D
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Nuclear Imaging Equipment Market, by region, 2020-2030 (USD Billion)
  • 1.2.2.Nuclear Imaging Equipment Market, by Modality, 2020-2030 (USD Billion)
  • 1.2.3.Nuclear Imaging Equipment Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Nuclear Imaging Equipment Market, by End-use, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Nuclear Imaging Equipment Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Nuclear Imaging Equipment Market Dynamics

• 3.1.Nuclear Imaging Equipment Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing incidence of cancer and cardiovascular diseases
    • 3.1.1.2.Increasing investments in healthcare infrastructure
    • 3.1.1.3.Rising adoption of hybrid imaging systems
  • 3.1.2.Market Challenges
    • 3.1.2.1.High Cost of Nuclear Imaging Equipment
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Expanding applications in neurology and oncology
    • 3.1.3.2.Favourable reimbursement policies for nuclear imaging procedures

Chapter 4.Global Nuclear Imaging Equipment Market: Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economic
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Nuclear Imaging Equipment Market, by Modality

• 5.1.Market Snapshot
• 5.2.Global Nuclear Imaging Equipment Market by Modality, Performance - Potential Analysis
• 5.3.Global Nuclear Imaging Equipment Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
• 5.4.Nuclear Imaging Equipment Market, Sub Segment Analysis
  • 5.4.1. SPECT
  • 5.4.2.PET

Chapter 6.Global Nuclear Imaging Equipment Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Nuclear Imaging Equipment Market by Application, Performance - Potential Analysis
• 6.3.Global Nuclear Imaging Equipment Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Nuclear Imaging Equipment Market, Sub Segment Analysis
  • 6.4.1. Cardiology
  • 6.4.2.Oncology
  • 6.4.3.Neurology
  • 6.4.4.Others

Chapter 7.Global Nuclear Imaging Equipment Market, by End-use

• 7.1.Market Snapshot
• 7.2.Global Nuclear Imaging Equipment Market by End-use, Performance - Potential Analysis
• 7.3.Global Nuclear Imaging Equipment Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
• 7.4.Nuclear Imaging Equipment Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2.Imaging Centers
  • 7.4.3.R&D
  • 7.4.4. Others

Chapter 8.Global Nuclear Imaging Equipment Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Nuclear Imaging Equipment Market, Regional Market Snapshot
• 8.4.North America Nuclear Imaging Equipment Market
  • 8.4.1.U.S. Nuclear Imaging Equipment Market
    • 8.4.1.1.Modality breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End-use breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Nuclear Imaging Equipment Market
• 8.5.Europe Nuclear Imaging Equipment Market Snapshot
  • 8.5.1.U.K. Nuclear Imaging Equipment Market
  • 8.5.2.Germany Nuclear Imaging Equipment Market
  • 8.5.3.France Nuclear Imaging Equipment Market
  • 8.5.4.Spain Nuclear Imaging Equipment Market
  • 8.5.5.Italy Nuclear Imaging Equipment Market
  • 8.5.6.Rest of Europe Nuclear Imaging Equipment Market
• 8.6.Asia-Pacific Nuclear Imaging Equipment Market Snapshot
  • 8.6.1.China Nuclear Imaging Equipment Market
  • 8.6.2.India Nuclear Imaging Equipment Market
  • 8.6.3.Japan Nuclear Imaging Equipment Market
  • 8.6.4.Australia Nuclear Imaging Equipment Market
  • 8.6.5.South Korea Nuclear Imaging Equipment Market
  • 8.6.6.Rest of Asia Pacific Nuclear Imaging Equipment Market
• 8.7.Latin America Nuclear Imaging Equipment Market Snapshot
  • 8.7.1.Brazil Nuclear Imaging Equipment Market
  • 8.7.2.Mexico Nuclear Imaging Equipment Market
• 8.8.Middle East & Africa Nuclear Imaging Equipment Market
  • 8.8.1.Saudi Arabia Nuclear Imaging Equipment Market
  • 8.8.2.South Africa Nuclear Imaging Equipment Market
  • 8.8.3.Rest of Middle East & Africa Nuclear Imaging Equipment Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1. GE HealthCare
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2. Siemens Healthineers
  • 9.3.3.Koninklijke Philips N.V.
  • 9.3.4.Canon Medical Systems Corporation
  • 9.3.5.Mediso, Cubresa Inc.
  • 9.3.6.Shimadzu Corporation
  • 9.3.7.United Imaging Healthcare Co
  • 9.3.8.BCL X-Ray Canada Inc.
  • 9.3.9.TTG Imaging Solutions, LLC.
  • 9.3.10.Lucerno Dynamics LLC.

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption